Glioblastoma (CPTAC, Cell 2021)

Summary

Glioblastoma (CPTAC, Cell 2021) is a study catalogued by cBioPortal DataHub under the cancer-type code difg. EvidenceHelix groups it with brain and nervous system studies.

Study description

Proteogenomic and metabolomic characterization of human glioblastoma. Whole genome or whole exome sequencing of 99 samples. Generated by CPTAC.

Text as published in the source's study metadata.

Citation & PubMed

Wang et al. Cell 2021

Linked PubMed records: PMID 33577785

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

gbm_cptac_2021

Short name

Glioblastoma (CPTAC, Cell 2021)

Source cancer-type code

difg

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Wang et al. Cell 2021

• PubMed record 33577785 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Brain Tumor PDXs (Mayo Clinic, Clin Cancer Res 2020)

  WES on a total of 106 PDXs and 80 PDXs have the matched germline (blood) samples sequenced. A total of 66 PDXs have RNASeq available

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Diffuse Glioma (GLASS Consortium, Nature 2019)

  Whole genome or whole exome sequencing analysis of temporally separated diffuse glioma tumor/normal pairs from 222 adult patients.

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Diffuse Glioma (GLASS Consortium)

  Whole genome or whole exome sequencing analysis of temporally separated diffuse glioma tumor/normal pairs from 329 adult patients. The data provided is based on the May 31, 2022 version and can be accessed at Synapse…

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 2

• Glioblastoma (Columbia, Nat Med. 2019)

  Whole-exome sequencing of 32 out of 42 glioblastomas patients with matched normals.

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Glioblastoma (Randomized Clinical Trial, Nat Med. 2019) - iAtlas Harmonized

  Whole-exome sequencing and neoantigen landscape analysis of 30 recurrent glioblastomas and their matched normals from a randomized, multi-institution clinical trial to evaluate immune responses and survival following…

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Low-Grade Gliomas (UCSF, Science 2014)

  Whole exome sequencing of 23 grade II glioma tumor/normal pairs.

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

• Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytoma (MSK, Neuro Oncol 2017)

  IMPACT sequencing of 22 Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytomas.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Brain Lower Grade Glioma (TCGA, Firehose Legacy)

  TCGA Brain Lower Grade Glioma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LGG/20160128/). Previously known as TCGA Provisional.

  Brain and nervous systemTCGA Firehose LegacySource code difg

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.